152 related articles for article (PubMed ID: 32190734)
1. Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients.
Duda I; Krzych Ł; Jędrzejowska-Szypułka H; Lewin-Kowalik J
Open Med (Wars); 2020; 15():50-56. PubMed ID: 32190734
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
3. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.
Hästbacka J; Linko R; Tervahartiala T; Varpula T; Hovilehto S; Parviainen I; Vaara ST; Sorsa T; Pettilä V
Anesth Analg; 2014 Apr; 118(4):790-8. PubMed ID: 24651234
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.
Hästbacka J; Fredén F; Hult M; Bergquist M; Wilkman E; Vuola J; Sorsa T; Tervahartiala T; Huss F
PLoS One; 2015; 10(5):e0125918. PubMed ID: 25945788
[TBL] [Abstract][Full Text] [Related]
7. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
[TBL] [Abstract][Full Text] [Related]
9. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 after burn injury.
Nagy B; Szélig L; Rendeki S; Loibl C; Rézmán B; Lantos J; Bogár L; Csontos C
J Crit Care; 2015 Feb; 30(1):162-6. PubMed ID: 25155253
[TBL] [Abstract][Full Text] [Related]
11. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.
Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T
J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665
[TBL] [Abstract][Full Text] [Related]
12. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
13. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy.
Susskind H; Hymowitz MH; Lau YH; Atkins HL; Hurewitz AN; Valentine ES; Meek AG; Zucker S
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1161-9. PubMed ID: 12829155
[TBL] [Abstract][Full Text] [Related]
15. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
[TBL] [Abstract][Full Text] [Related]
16. Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
Cakirca G; Turgut FH
Iran J Kidney Dis; 2018 Oct; 12(5):299-304. PubMed ID: 30367022
[TBL] [Abstract][Full Text] [Related]
17. Plasma MMP-9 and TIMP-1 levels on ICU admission are associated with 30-day survival.
Jordakieva G; Budge-Wolfram RM; Budinsky AC; Nikfardjam M; Delle-Karth G; Girard A; Godnic-Cvar J; Crevenna R; Heinz G
Wien Klin Wochenschr; 2021 Feb; 133(3-4):86-95. PubMed ID: 31932967
[TBL] [Abstract][Full Text] [Related]
18. Levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are related to cardiopulmonary injury in fetal inflammatory response syndrome.
Yan Y; Jiang L; Li M; Zhang H; Shen Y; Zhang W; Zhang W
Clinics (Sao Paulo); 2020; 75():e2049. PubMed ID: 33263620
[TBL] [Abstract][Full Text] [Related]
19. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.
Lauhio A; Hästbacka J; Pettilä V; Tervahartiala T; Karlsson S; Varpula T; Varpula M; Ruokonen E; Sorsa T; Kolho E
Pharmacol Res; 2011 Dec; 64(6):590-4. PubMed ID: 21742038
[TBL] [Abstract][Full Text] [Related]
20. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
